Ginkgo Bioworks Holdings (DNA) executive compensation, 2026 proxy

Jason Kelly, Chief Executive Officer, was paid $5.7M in fiscal 2025, up 364% from $1.2M the year before. The CEO-to-median-employee pay ratio was 32:1, on median employee pay of $176,436.

Filed
April 29, 2026
Annual meeting
June 11, 2026
Pay year
fiscal 2025
Named executives
4
CEO total pay
$5.7M+364% vs prior year
CEO to median employee
32:1median $176,436
CEO pay in equity
96%$5.5M in awards
CEO Total Compensation
$5,709,049Fiscal 2025 compensation
CEO Pay Ratio
32:1Ratio to median employee
Median Employee Pay
$176,436Annual total compensation
CEO Base Salary
$250,000Unchanged from prior year

How Kelly was paid

$5.7M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary4%Stock awards96%All other compensation0%

Named executive officers

ExecutiveTotal
Jason KellyChief Executive Officer$5,709,049
Reshma ShettyPresident & Former Chief Operating Officer$3,479,364
Steven CoenChief Financial Officer$1,332,326
Mark DmytrukFormer Chief Financial Officer$386,941

What changed and why

  • $5.7MJason Kelly received total compensation of $5,709,049 in fiscal 2025 compared to $1,231,000 in fiscal 2024.
  • Chief executive officer stock awards for 2025 included performance-based restricted stock units tied to cash flow metrics.
  • Steven Coen was appointed as Chief Financial Officer effective May 30, 2025.
  • Mark Dmytruk resigned as Chief Financial Officer effective June 6, 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.